Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
As a distance runner, Carly Anderson may be setting the pace for the future of GLPs
Disclosures: Khalis Mustafayev: Nothing to Disclose, Nicholas Short: Nothing to Disclose, Kelly Chien: Nothing to Disclose, Naval Daver: Nothing to Disclose, Fareed Khawaja: SymBio: Grant/Research Support, Eurofins Viracor: Grant/Research Support, Harrys Torres: Gilead: Principal Investigator, Merck: Principal Investigator, AIM Specialty Health: Consultant 380 IMPACT OF COVID-19 PANDEMIC ON TREATMENT FOR HEPATITIS B IN BRITISH COLUMBIA, CANADA: AN INTERRUPTED TIME SERIES ANALYSIS Richard Morrow 1 Dahn Jeong 1 Jean Makuza 1 Michael Irvine 2 Alnoor Ramji 1 Hin Hin Ko 1 Mel Krajden 2 Sofia Bartlett 1 Stanley Wong 2 Amanda Yu 2 JASON WONG 2 Julia Li 2 Naveed Janjua 1 , 1 University of British Columbia, 2 BC Centre for Disease Control Background: Previous research suggests the COVID-19 pandemic was associated with reduced treatment for hepatitis B (HBV) early in the pandemic
It is typically intended for long-term use under the guidance of a healthcare professional
Diazoxide choline does not cure the disease, it controls it
Do I need a prescription or specific diagnosis for GLP-1
